ZANGHI', AURORA

ZANGHI', AURORA  

Università degli Studi di CATANIA  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.049 secondi).
Titolo Data di pubblicazione Autore(i) File
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 1-gen-2019 D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Zappia, Mario; Patti, Francesco
Can new chemical therapies improve the management of multiple sclerosis in children? 1-gen-2017 D'Amico, E; Zanghì, A; Patti, Francesco
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 1-gen-2019 D'Amico, Emanuele; Chisari, Clara G.; Arena, Sebastiano; Zanghì, Aurora; Toscano, Simona; Lo Fermo, Salvatore; Maimone, Davide; Castaing, Marine; Sciacca, Salvatore; Zappia, Mario; Patti, Francesco
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 1-gen-2018 D'Amico, Emanuele; Zanghì, Aurora; Callari, Graziella; Borriello, Giovanna; Gallo, Antonio; Graziano, Giusi; Valentino, Paola; Buccafusca, Maria; Cottone, Salvatore; Salemi, Giuseppe; Ragonese, Paolo; Bossio, Roberto Bruno; Docimo, Renato; Grimaldi, Luigi Maria Edoardo; Pozzilli, Carlo; Tedeschi, Gioacchino; Zappia, Mario; Patti, Francesco
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 1-gen-2020 D'Amico, E.; Zanghi, A.; Sciandra, M.; Lanzillo, R.; Callari, G.; Cortese, A.; Lus, G.; Lucchini, M.; Buccafusca, M.; Bonavita, S.; Gallo, A.; Curti, E.; Gajofatto, A.; Signoriello, E.; Bisecco, A.; Gobbin, F.; Ferro, M. T.; Ferrazzano, G.; Sparaco, M.; Valentino, P.; Mirabella, M.; Granella, F.; Bresciamorra, V.; Grimaldi, L. M. E.; Patti, F.; Borriello, G.; Grossi, P.; Carotenuto, A.; Siena, E.; Tsantes, E.; Abbadessa, G. M.; Chisari, C. G.
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 1-gen-2019 D’Amico, E.; Zanghì, A.; Sciandra, M.; Borriello, G.; Callari, G.; Gallo, A.; Salemi, G.; Cottone, S.; Buccafusca, M.; Valentino, P.; Bossio, R. B.; Grimaldi, L. M. E.; Pozzilli, C.; Tedeschi, G.; Zappia, M.; Patti, F.
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 1-gen-2019 D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Fermo, Salvatore Lo; Toscano, Simona; Arena, Sebastiano; Patti, Francesco; Zappia, Mario
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 1-gen-2021 Zanghì, Aurora; Gallo, Antonio; Avolio, Carlo; Capuano, Rocco; Lucchini, Matteo; Petracca, Maria; Bonavita, Simona; Lanzillo, Roberta; Ferraro, Diana; Curti, Erica; Buccafusca, Maria; Callari, Graziella; Barone, Stefania; Pontillo, Giuseppe; Abbadessa, Gianmarco; Di Francescantonio, Valeria; Signoriello, Elisabetta; Lus, Giacomo; Sola, Patrizia; Granella, Franco; Valentino, Paola; Mirabella, Massimiliano; Patti, Francesco; D'Amico, Emanuele
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 1-gen-2020 D'Amico, Emanuele; Zanghì, Aurora; Burgio, Giovanni; Chisari, Clara Grazia; Condorelli, Rosita Angela; La Vignera, Sandro; Calogero, Aldo Eugenio; Patti, Francesco
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment 1-gen-2020 Zanghi, A.; D'Amico, E.; Patti, F.
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 1-gen-2018 D'Amico, E; Patti, F; Zanghì, A; Chisari, C G; Lo Fermo, S; Zappia, M
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 1-gen-2018 D’Amico, E.; Patti, F.; Zanghi', Aurora; Lo Fermo, S.; Chisari, C. G.; Zappia, M.
Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: A prospective case-control study 1-gen-2021 D'Amico, Emanuele; Zanghì, Aurora; Calogero, Aldo Eugenio; Patti, Francesco
Management of dysphagia in multiple sclerosis: current best practice 1-gen-2019 D’Amico, Emanuele; Zanghì, Aurora; Serra, Agostino; Murabito, Paolo; Zappia, Mario; Patti, Francesco; Cocuzza, Salvatore
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience 1-gen-2020 Zanghì, Aurora; D'Amico, Emanuele; Luca, Maria; Ciaorella, Marco; Basile, Lucia; Patti, Francesco
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 1-gen-2019 D'Amico, Emanuele; Zanghì, Aurora; Romano, Alessandra; Sciandra, Mariangela; Palumbo, Giuseppe Alberto Maria; Patti, Francesco
Pharmacoeconomics of synthetic therapies for multiple sclerosis 1-gen-2019 D’Amico, E.; Chisari, C. G.; Gitto, L.; Zanghì, A.; Toscano, S.; Patti, F.
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 1-gen-2020 Zanghi, A.; Cimino, S.; Urzi, D.; Privitera, S.; Zagari, F.; Lanza, G.; Patti, F.; D'Amico, E.
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives 1-gen-2019 D'Amico, E; Zanghì, A; Gastaldi, M; Patti, F; Zappia, M; Franciotta, D
An update on the safety of treating relapsing-remitting multiple sclerosis 1-gen-2019 Chisari, Clara G; Toscano, Simona; D'Amico, Emanuele; Lo Fermo, Salvatore; Zanghì, Aurora; Arena, Sebastiano; Zappia, Mario; Patti, Francesco